Patent Assignment
Reel/Frame 038180/0021
Security Agreement
Recorded: 2016-03-21
Pages: 17
Assignor
OREXIGEN THERAPEUTICS, INC.
Executed: 2016-03-21
Assignee
U.S. BANK NATIONAL ASSOCIATION, AS COLLATERAL AGENT
60 LIVINGSTON AVENUE, ST. PAUL, MINNESOTA, 55107
Covered Properties
(43)
Zonisamide use in obesity and eating disorders
Application:
10/429,474 →
Publication:
US 2004/0029941
Compositions for Affecting Weight Loss
Zonisamide use in eating disorders
Application:
10/932,047 →
Publication:
US 2005/0026977
Compositions of an Anticonvulsant and an Antipsychotic Drug and Methods of Using the Same for Affecting Weight Loss
Method for treating obesity
Application:
11/059,021 →
Publication:
US 2005/0215552
Compositions for affecting weight loss
Application:
11/109,027 →
Publication:
US 2006/0100205
Combination of bupropion and a second compound for affecting weight loss
Application:
11/194,201 →
Publication:
US 2006/0058293
Compositions for Affecting Weight Loss
Methods and Compositions for Managing Psychotic Disorders
Application:
11/420,385 →
Publication:
US 2006/0276412
Compositions for affecting weight loss
Application:
11/492,685 →
Publication:
US 2007/0117827
Sustained-Release Formulation of Zonisamide
Application:
11/563,618 →
Publication:
US 2007/0148237
Methods of Treating Anxiety Disorders
Application:
11/563,631 →
Publication:
US 2007/0179168
Compositions and methods for increasing insulin sensitivity
Compositions and methods for reducing food cravings
Application:
11/602,813 →
Publication:
US 2007/0129283
Compositions of an Anticonvulsant and Methods of Using the Same for Reversing Weight Gain
Application:
11/622,363 →
Publication:
US 2007/0185084
Sustained Release Formulation of Naltrexone
Methods for Administering Weight Loss Medications
Application:
11/937,367 →
Publication:
US 2008/0110792
Layered Pharmaceutical Formulations
Methods for Administering Weight Loss Medications
Methods of Providing Weight Loss Therapy in Patients with Major Depression
Methods for Treating Visceral Fat Conditions
Application:
12/995,121 →
Publication:
US 2011/0144145
Layered Pharmaceutical Formulations
Layered Pharmaceutical Formulations
Application:
13/680,922 →
Publication:
US 2013/0177602
Methods for Reducing Binge or Compulsive Eating
Application:
13/991,372 →
Publication:
US 2013/0252995
Compositions and Methods for Reducing Food Cravings
Application:
14/207,077 →
Publication:
US 2014/0309252
Methods for Administering Weight Loss Medications
Compositions and Methods for Weight Loss in at Risk Patient Populations
Patent:
8,969,371 →
Application:
14/322,810 →
Compositions and Methods for Increasing Insulin Sensitivity
Methods of Treating Overweight and Obesity
Method for Treating Obesity
Application:
14/464,622 →
Publication:
US 2014/0364468
Layered Pharmaceutical Formulations
Application:
14/541,525 →
Publication:
US 2015/0164806
Sustained Release Formulation of Naltrexone
Methods for Treating Visceral Fat Conditions
Application:
14/584,985 →
Publication:
US 2015/0119417
Compositions for Affecting Weight Loss
Application:
14/602,154 →
Publication:
US 2015/0141452
Compositions and Methods for Weight Loss in at Risk Patient Populations
Method for Treating Obesity
Application:
14/663,338 →
Publication:
US 2015/0320726
Sustained Release Formulation of Naltrexone
Application:
14/826,086 →
Publication:
US 2016/0158221
Compositions and Methods for Weight Loss in at Risk Patient Populations
Methods for Administering Weight Loss Medications
Application:
14/844,476 →
Publication:
US 2016/0193152
Layered Pharmaceutical Formulations
Application:
14/988,556 →
Publication:
US 2016/0338965
Methods for Prophylatic Appetite Suppression
Application:
15/004,269 →
Publication:
US 2016/0354348
Methods of Providing Weight Loss Therapy in Patients with Major Depression
Sustained Release Formulation of Naltrexone
Application:
15/046,373 →
Publication:
US 2016/0158225
Related Assignments
(8)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Mar 18, 2014
From: MCKINNEY, ANTHONY; TOLLEFSON, GARY; WEBER, ECKARD; SOLTERO, RICK
To: OREXIGEN THERAPEUTICS, INC.
Reel/Frame 032463/0479 →
Assignment of Assignor's Interest
Dec 18, 2015
From: DUNAYEVICH, EDUARDO; DEWITT (LEGAL REPRESENTATIVE OF GARY TOLLEFSON (DECEASED)), DAVID
To: OREXIGEN THERAPEUTICS, INC.
Reel/Frame 037334/0490 →
Assignment of Assignor's Interest
Mar 22, 2017
From: WEBER, ECKARD; COWLEY, MICHAEL ALEXANDER
To: OREXIGEN THERAPEUTICS, INC.
Reel/Frame 041688/0847 →
Assignment of Assignor's Interest
Aug 2, 2018
From: OREXIGEN THERAPEUTICS, INC.
To: NALPROPION PHARMACEUTICALS, INC.
Reel/Frame 046688/0661 →
Security Interest
Aug 6, 2018
From: NALPROPION PHARMACEUTICALS, INC.
To: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS COLLATERAL AGENT
Reel/Frame 047288/0321 →
Release of Security Interest
Sep 27, 2019
From: WILMINGTON SAVINGS FUND SOCIETY, FSB
To: NALPROPION PHARMACEUTICALS, INC.
Reel/Frame 050574/0106 →
Change of Name
Oct 17, 2019
From: NALPROPION PHARMACEUTICALS, INC.
To: NALPROPION PHARMACEUTICALS LLC
Reel/Frame 050750/0497 →
Security Interest
Dec 19, 2019
From: CURRAX PHARMACEUTICALS LLC; NALPROPION PHARMACEUTICALS LLC
To: WILMINGTON SAVINGS FUND SOCIETY, FSB
Reel/Frame 051377/0958 →